Indian drugmaker Gujarat Themis Biosyn Ltd. has secured private credit funding to support its purchase of Japan’s MicroBiopharm Japan Co., underscoring the rising use of private debt for overseas expansion in Asia.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
